ResMed(RMD)

Leader

ResMed (RMD) reported ~$4.7B revenue in FY2024. Global leader in cloud-connected devices for sleep apnea, COPD, and out-of-hospital care, with 10M+ connected devices. HQ: San Diego.

Sleep & Respiratory Devices
RMD
Visit Website
Updated March 2026

Company Overview

About ResMed

ResMed Inc. is the global leader in cloud-connected medical devices and software for diagnosing and treating sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions in out-of-hospital settings. Founded in Sydney, Australia in 1989, the company designs and manufactures CPAP (continuous positive airway pressure) machines, masks, ventilators, and related accessories used by patients with obstructive sleep apnea — a condition affecting approximately 1 billion people globally that is chronically under-diagnosed and under-treated.

Business Model & Competitive Advantage

ResMed reported approximately $4.7 billion in revenue in FY2024, with its Devices segment (CPAP machines, ventilators) and Masks & Accessories segment contributing roughly equally. ResMed has over 10 million cloud-connected devices globally, streaming anonymized health data through the AirView platform that allows physicians and home medical equipment providers to monitor patient compliance and adjust therapy remotely. This data advantage — the largest real-world sleep apnea dataset — enables continuous product improvement and supports outcomes-based contracting with payers.

Competitive Landscape 2025–2026

The GLP-1 drug phenomenon (Ozempic, Wegovy) briefly pressured ResMed's stock as investors worried weight loss drugs would reduce CPAP demand by addressing obesity-driven sleep apnea. ResMed's analysis of its own data showed existing CPAP users are not abandoning therapy, and GLP-1 uptake may actually increase sleep apnea diagnosis rates by drawing patients to physicians who discover the condition. The software segment (Brightree for HME billing, MatrixCare for long-term care) adds SaaS diversification and is growing at higher rates than devices.

Revenue
$4700M
Curated content • Fact-checked and verified
Loading News...
Loading Culture...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Market Leader

ResMed is recognized as a market leader in the Healthcare Tech sector, demonstrating strong industry presence and customer trust.

Enterprise Scale

With $4700M in revenue, ResMed operates at enterprise scale with proven market validation.

Frequently Asked Questions

Not So Random Others

YouShift

Healthcare Tech
HealthtechManufacturing

YouShift is a United States-based AI healthcare workforce management platform — building the operating system for healthcare staffing starting with AI-powered scheduling agents that replace the comple

Hermes Robotics

Manufacturing
B2bHardwareManufacturingAi PoweredAutomationStartup

Hermes Robotics is an autonomous mobile robot (AMR) and warehouse automation company developing robots and software for logistics and fulfillment operations in warehouses, distribution centers, and ma

Brisk

Consumer Food & Beverage
B2cManufacturingNorth AmericaFortune500

Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione

Bucket Robotics

Manufacturing
B2bHardwareManufacturingAi PoweredAutomationStartup

Bucket Robotics is an autonomous mobile robot (AMR) company that designs modular, rapidly deployable robots for warehouse automation and industrial material handling. Unlike traditional warehouse auto

Altria

Consumer Goods
B2cManufacturingNorth AmericaPublicFortune500

Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s

Dusty Robotics

Infrastructure
B2bPlatformManufacturing

Dusty Robotics is a Mountain View, California-based construction robotics company — backed with $69.5 million in total funding from Root Ventures, Scale Venture Partners, Canaan Partners, GRIDS Capita

Compare ResMed with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For ResMed

Claim This Profile

Are you from ResMed? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim ResMed Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention ResMed vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →